ScripsAmerica, Inc.

SCRCQ

US8110661092

Drug Retailers

Market Closed - OTC Markets Other stock markets 20:10:00 2023-12-01 EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2018	AEM Medical Group LLC cancelled the acquisition of 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	CI
2018	Jaysukh Sabhaya cancelled its acquisition of Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	CI

ScripsAmerica, Inc. Secures $200,000 Purchase Order for RapiMed(R) from Global Pharma Hub for the Hong Kong Market

March 10, 2014 at 08:30 am

ScripsAmerica, Inc. announced that the company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market. ScripsAmerica's RapiMed(R) Pain Reliever and Fever Reducer for children will be supplied to a network of independent pharmacies operating in Hong Kong. Consumers in Hong Kong and China are driving the demand for safe and reliable American made OTC medications like RapiMed due to environmental hazards, counterfeit medications and quality control concerns across Asia, cites ScripsAmerica.

Latest news about ScripsAmerica, Inc.

AEM Medical Group LLC cancelled the acquisition of 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	18-03-29	CI
Jaysukh Sabhaya cancelled its acquisition of Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q).	18-01-17	CI
Motion for Joint Administration Approved for ScripsAmerica, Inc.	17-09-15	CI
Motion for Joint Administration Filed by ScripsAmerica, Inc.	17-08-28	CI
Affiliate Company Joined ScripsAmerica, Inc. Bankruptcy	17-07-21	CI
Motion for Asset Sale Approved for ScripsAmerica, Inc.	17-03-30	CI
AEM Medical Group LLC entered into asset purchase agreement to acquire 90% equity interest of PIMD International LLC from ScripsAmerica, Inc. (OTCPK:SCRC.Q) $0.03.	17-03-29	CI
Motion for Asset Sale Filed by ScripsAmerica, Inc.	17-03-10	CI
Motion For Case Conversion Approved for ScripsAmerica, Inc.	17-02-08	CI
Motion for Case Conversion Filed by ScripsAmerica, Inc.	17-01-29	CI
Motion for Asset Sale Approved for ScripsAmerica, Inc.	17-01-24	CI
Notice for Asset Purchase Agreement Filed by ScripsAmerica, Inc.	17-01-24	CI
Jaysukh Sabhaya entered into an asset purchase agreement to acquire Pharmacy Administration, Inc. from ScripsAmerica, Inc. (OTCPK:SCRC.Q) for $0.15 million.	17-01-23	CI
Liquidation Plan and Disclosure Statement Filed by ScripsAmerica, Inc.	17-01-15	CI
First Motion for Exclusivity Period Extension Filed by ScripsAmerica, Inc.	17-01-03	CI
First Motion for Exclusivity Period Extension Withdrawn by ScripsAmerica, Inc.	16-11-29	CI
First Motion for Exclusivity Period Extension Filed by ScripsAmerica, Inc.	16-11-14	CI
Bidding Procedure Approved for ScripsAmerica, Inc.	16-11-03	CI
Motion for Asset Sale Filed by ScripsAmerica, Inc.	16-10-14	CI
ScripsAmerica, Inc. will Change its Ticker to SCRC.Q from SCRC	16-09-09	CI
ScripsAmerica, Inc. Filed for Bankruptcy	16-09-07	CI
ScripsAmerica, Inc. Announces Board Changes	16-07-20	CI
ScripsAmerica, Inc. Announces Resignation of Anderson Triggs as Director	16-06-16	CI
ScripsAmerica, Inc. Reports Earnings Results for the Fiscal 2014	16-02-01	CI
ScripsAmerica Mulls Acquisitions	15-08-18	CI

Chart ScripsAmerica, Inc.

Duration

Period

More charts

Company Profile

ScripsAmerica, Inc. is engaged in the distribution of prescription and over the counter pharmaceuticals. The Company's subsidiaries include Main Avenue Pharmacy Inc. (Main Avenue), DispenseDoc Inc. (DispenseDoc) and Pharmacy Administration, Inc. (Pharmacy Administration). It also holds interests in P.I.M.D. International LLC (PIMD). Its operations consist of the sale and compounding of non-sterile topical and transdermal pain creams through Main Avenue; wholesale sales to independent pharmacies and other medical providers through PIMD; pharmacy dispensing services for individual doctors through DispenseDoc, and billing and administrative services through Pharmacy Administration. Main Avenue's prescription pain creams incorporate approximately eight active pharmaceutical ingredients for application on the skin and in localized areas. As of December 31, 2014, PIMD held licenses in over 20 states to receive, store and ship Schedule 3 through Schedule 5 formulary pharmaceuticals.

Sector

Drug Retailers

More about the company

Sector Other Drug Retailers

	1st Jan change	Capi.
SCRIPSAMERICA, INC.	-.--%	141
WALGREENS BOOTS ALLIANCE, INC.	-41.10%	13.27B
JD HEALTH INTERNATIONAL INC.	-29.54%	11.76B
YIFENG PHARMACY CHAIN CO., LTD.	+14.31%	6.38B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-16.75%	6.96B
MATSUKIYOCOCOKARA & CO.	-13.48%	5.88B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+72.00%	4.98B
NAHDI MEDICAL COMPANY	-3.36%	4.59B
CLICKS GROUP LIMITED	-6.07%	3.98B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-18.47%	3.19B

Other Drug Retailers